SEC Form 4 · accession 0001562180-18-002938
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles R. Kummeth
Officer — Chief Executive Officer · Director
Period of report
Jun 7, 2018
Accepted (ET)
Jun 8, 2018 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 7, 2018 | S | 8,000 | $160.00 | D | 76,472 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3,F4 | — | holding | — | — | — | — | — | Common Stock | 17,283 | 17,283 | D |
| Restricted Stock UnitF3,F5 | — | holding | — | — | — | — | — | Common Stock | 24,979 | 24,979 | D |
| Restricted Stock UnitF3,F6 | — | holding | — | — | — | — | — | Common Stock | 21,291 | 21,291 | D |
| Stock Option (Right to Buy)F7 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 79,517 | 79,517 | D |
| Stock Option (Right to Buy)F4 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 119,275 | 119,275 | D |
| Stock Option (Right to Buy)F8 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 102,779 | 102,779 | D |
| Stock Option (Right to Buy)F5 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 154,169 | 154,169 | D |
| Stock Option (Right to Buy)F9 | $86.25 | holding | — | — | — | — | Apr 1, 2021 | Common Stock | 46,316 | 46,316 | D |
| Stock Option (Right to Buy)F10 | $67.46 | holding | — | — | — | — | Apr 1, 2020 | Common Stock | 65,000 | 65,000 | D |
| Stock Option (Right to Buy)F10 | $67.46 | holding | — | — | — | — | Apr 1, 2020 | Common Stock | 50,000 | 50,000 | D |
| Stock Options (Right to buy)F6 | $125.05 | holding | — | — | — | — | Aug 9, 2024 | Common Stock | 117,342 | 117,342 | D |
| Stock Options (Right to buy)F11 | $125.05 | holding | — | — | — | — | Aug 9, 2024 | Common Stock | 78,228 | 78,228 | D |
| Stock Options (Right to buy)F10 | $94.35 | holding | — | — | — | — | Aug 12, 2021 | Common Stock | 66,849 | 66,849 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 23, 2018.
- F10Fully exercisable
- F11Vests 19,557 each on 8/9/2018, 8/9/2019, 8/9/2020, 8/9/2021
- F2Includes (i) 10,203 shares for which the risk of forfeiture will lapse pursuant to achievement of performance goals; (ii) 3,841 shares for which the risks of forfeiture will lapse on August 7, 2018; and (iii) 11,102 shares for which the risks of forfeiture will lapse with respect to 5,551 shares on each of August 18, 2018 and August 18, 2019; and (iv) 4,731 shares each which risks of forfeiture will lapse on August 9, 2018 and August 9, 2019; and (v) 4,732 shares for which risks of forfeiture will lapse on August 9, 2020
- F3Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F4Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F5Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F6Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F719,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019.
- F8Vests 25,695 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 25,694 shares on 8/18/20.
- F9The option will vest pursuant to the following schedule: 5,790 shares on October 1, 2014, 965 shares on the first day of the month for the period beginning November 1, 2014 and ending March 1, 2018, and 961 shares on April 1, 2018.